Enigmatig LTD is a US-listed company in the research & consulting services industry. Its financial year ends in September.
Stock price today
Loading chart…
Third-party market data · may be delayed
Fair value per share
Under review: every model's value for Enigmatig LTD is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.
Price vs value
Under review: cash-flow, stock-pay or share-count figures missing or out of date. We'll show the comparison once resolved.
Enigmatig LTD valuation: adjust assumptions and compare models →
Who’s trading
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
- Funds1 adding, 0 cuttingOf 0 active managers that changed their stake, 0 added; quarter to June 30, 2026Fund buyers and sellers
The Fundamentalytics view
Enigmatig LTD's trailing-twelve-month revenue grew 12.2% year on year, with a free-cash-flow margin of -44.1%. Where it stands out: change in growth rate of +26.1pp ranks 2 of 33 research & consulting services companies we cover. Where it lags: free-cash-flow margin of -44.1% ranks 29 of 33 research & consulting services companies we cover.
Current signal Balance sheet growing far ahead of sales: Total assets grew 423% year over year while revenue grew 12% — the balance sheet is expanding 411 points faster than the business it supports.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Highlights
How we pick theseStrengths
- Growth speeding up. The growth rate is 26.1 points higher than a quarter earlier.
- Net cash. Cash exceeds long-term debt by $0.0bn.
Things to watch
- Margins narrowing. Operating margin is down 13.7 points on a year ago.
- Burning cash. Free cash flow was -44.1% of revenue over the last 12 months.
- Share dilution. Diluted shares rose 3.5% in a year.
- Volatile shares. Over the past year the shares showed annualised volatility of 165% and a beta of 0.5 against the S&P 500.
- Weak cash conversion. Free cash flow was -350% of net income over the last 12 months.
- Below peers: days sales outstanding. Days sales outstanding of 101 days ranks 25 of 29 research & consulting services companies we cover (median 63 days).
Price chart
- 1 day+0.7%
- 1 week-4.0%
- 1 month-8.0%
- This year-5.8%
- 1 year+26.1%
- S&P 500 this year+11.2%
Loading chart…
Third-party market data · may be delayed
At a glance
Profitability
- Revenue (TTM)
- $4.5M
- Operating margin
- 12.1%
- Net margin
- 12.6%
- EPS (TTM, diluted)
- $0.02
Growth
- Revenue growth
- +12.2%
- Change in growth rate
- +26.1 pts
- Share count change
- +3.5%
Cash
- Free cash flow (TTM)
- -$2M
- FCF margin
- -44.1%
News & updates
Company announcements, filed results and changes that matter to shareholders.
No recent updates are available for EGG from the sources we follow. See filings →
The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.
Valuation models
We value Enigmatig LTD as an operating company, with every model that fits that kind of business. Cost of equity 8.9%: the 10-year Treasury yield (4.9%) plus a beta of 0.89 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. | ~$0.5 ~$0.4–$0.6 | Left out: out of range vs price (0.09x) |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | — | Does not apply: This model is withheld pending its input or assumption review. |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | ~$0.5 ~$0.5–$0.6 | Left out: out of range vs price (0.11x) |
| Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. | ~$0.4 ~$0.4–$0.5 | Left out: out of range vs price (0.09x) |
| Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. | — | Does not apply: This model is withheld pending its input or assumption review. |
| Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. | — | Combined value withheld. Review the individual models and their assumptions. |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Enigmatig LTD with Research & Consulting Services in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Valuation multiples over time Market data may be delayed
| At fiscal year end | 2025 |
|---|---|
| Share price | $5.80 |
| Market value | $150m |
| + Net debt (− = net cash) | −$13m |
| Enterprise value | $137m |
| Multiples | |
| Price / sales | 33.7x |
| Price / earnings | n/m |
| Price / free cash flow | — |
| EV / EBITDA | n/m |
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: High.
Forecasts and guidance
Analysts' consensus
No analyst estimates are published for Enigmatig LTD: too few analysts cover it.
Positioning
- Short interest
- 0.7% of tradable shares
- Days to cover
- 0.18 at average volume
- Short interest, 1 month
- −40% to October 15, 2026
- Held by institutions
- 0% of shares
- Held by insiders
- 32.6% of shares
- Employees
- 27 full time
Share-price performance
Market data may be delayedReturn and risk by year
| Calendar year | 2026 to date |
|---|---|
| Return | |
| EGG | −6% |
| Industry peers (median) | −0% |
| S&P 500 | +11% |
| Months that ended higher | |
| EGG | 55% |
| S&P 500 | 46% |
| Largest fall from a high during the year | |
| EGG | −81% |
| S&P 500 | −9% |
Worst fall since June 18, 2025: 81% from June 4, 2026 to July 27, 2026. Getting back needed a 429% gain, and the shares have not yet recovered.
Price behaviour
- 52-week range
- $2.05 – $10.85
- From 52-week high
- −54.4%
- vs 50-day average
- +27.4%
- vs 200-day average
- −12.0%
- Volatility (1 year)
- 165%
- Beta vs S&P 500
- 0.53
Enigmatig LTD in five measures
Fundamentals
Where the money goes
Each dollar Enigmatig took in during FY2025, followed through to profit: what it cost to make, what went on running the business, and what was left after tax.
| Revenue | $4.5M | |
|---|---|---|
| Other income | $317,168 | 7.1% of revenue |
| Cost of revenue | $1.4M | 31.2% of revenue |
| Gross profit | $3.1M | 68.8% of revenue |
| Other operating costs | $2.5M | 56.7% of revenue |
| Operating income | $537,997 | 12.1% of revenue |
| Income tax | $295,502 | 6.6% of revenue |
| Net income | $559,663 | 12.6% of revenue |
Financial statements
| Fiscal year | 2023 Sept 2023 | 2024 Sept 2024 | 2025 Sept 2025 |
|---|---|---|---|
| Income | |||
| Revenue | 5 | 4 | 4 |
| Gross profit | 3 | 3 | 3 |
| EBITDA | 1 | 1 | 1 |
| Operating income | 1 | 1 | 1 |
| Net income | 1 | 1 | 1 |
| Diluted EPS | $0.05 | $0.03 | $0.02 |
| Growth (year on year) | |||
| Revenue | — | −13.9% | +12.2% |
| EBITDA | — | −30.6% | −44.5% |
| Operating income | — | −30.9% | −47.4% |
| Net income | — | −27.6% | −31.8% |
| Diluted EPS | — | −40.0% | −33.3% |
| Margins | |||
| Gross margin | 68.0% | 67.1% | 68.8% |
| EBITDA margin | 32.2% | 25.9% | 12.8% |
| Operating margin | 32.1% | 25.8% | 12.1% |
| Net margin | 24.6% | 20.7% | 12.6% |
| Free-cash-flow margin | −1.4% | −15.3% | −44.1% |
| Cash flow | |||
| Cash from operations | −0 | −1 | −2 |
| Capital spending | 0 | 0 | 0 |
| Free cash flow | −0 | −1 | −2 |
| Balance sheet | |||
| Cash | 1 | 2 | 13 |
| Total debt | 0 | 0 | 0 |
| Net debt (negative = net cash) | −1 | −2 | −13 |
| Diluted shares | 25m | 25m | 26m |
Financial health
- Short-term assets cover short-term liabilities $15m of assets due within a year against $2m of liabilities due within a year.
- Short-term assets cover long-term liabilities $15m short-term assets against $407,622 of longer-dated liabilities.
- More cash than debt Cash or debt not separately reported. Not assessable.
- Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
- Operating profit covers interest at least five times over Interest not separately reported. Not assessable.
Dividends, buybacks and capital spending
- Diluted share count
- +3.5%
- year over year
- Days sales outstanding
- 101 days
- receivables vs revenue
Competitors: side by side with peers
| Last 12 months unless stated | EGG | ACCL | ZTG | LAWR | INTJ | RYOJ | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $4m | $5m | $3m | $8m | $2m | $9m | $632m |
| Revenue growth, last 12 months | 12.2% | 5.8% | 55.8% | 62.5% | −8.8% | −19.4% | 4.8% |
| Gross margin | 68.8% | 42.7% | — | 49.1% | 63.8% | 26.6% | 43.9% |
| Operating margin | 12.1% | 4.5% | — | −120.4% | −108.2% | −8.1% | 6.1% |
| Net margin | 12.6% | 5.6% | 31.7% | −121.2% | −98.3% | 1.3% | 3.1% |
| Cash from operations / revenue | −38.5% | 11.1% | −115.8% | −101.1% | −1.0% | 9.3% | 9.6% |
| Free-cash-flow margin | −44.1% | 10.6% | −115.8% | −101.1% | −5.5% | 7.4% | 7.4% |
| Stock pay / revenue | — | — | — | 1.3% | 101.2% | 5.8% | 2.5% |
| Change in share count | 3.5% | 8.1% | 0.4% | 6.3% | 56.0% | 5.1% | 0.5% |
Peer comparison
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | 12.2% | 4.8% | 9 of 33 |
| Change in growth rate Growth | +26.1pp | +0.6pp | 2 of 33 |
| Gross margin Profitability | 68.8% | 45.2% | 6 of 25 |
| Operating margin Profitability | 12.1% | 6.1% | 6 of 31 |
| Net margin Profitability | 12.6% | 3.1% | 7 of 33 |
| Free-cash-flow margin Cash generation | -44.1% | 7.4% | 29 of 33 |
| Change in share count Balance sheet | 3.5% | 0.6% | 19 of 30 |
| Days sales outstanding Balance sheet | 101 days | 63 days | 25 of 29 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
Who owns it
Funds buying and selling- Reported value
- $6,034
- Institutions reporting
- 1
- Positions opened / closed
- 1 / 0
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| UBS Group AG | $6,034 | 1K | 100.0% | — |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Enigmatig LTD's complete shareholder register. Values are as reported by the filers .
Insider trading activity
Full insider history and chartFrom insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
Earnings dates and SEC filings
Data status
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
Enigmatig LTD in brief
- What does Enigmatig LTD do?
- Enigmatig LTD is a US-listed company in the research & consulting services industry. Its financial year ends in September.
- What is Enigmatig LTD's stock ticker?
- Enigmatig LTD trades under the ticker EGG on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
- What is Enigmatig LTD's revenue, and how fast is it growing?
- Over its most recent trailing twelve months, Enigmatig LTD reported revenue of $4.5M, 12.2% higher than a year earlier, according to its SEC filings.
- What is Enigmatig LTD's free cash flow?
- Enigmatig LTD's free-cash-flow margin is -44.1% of revenue over the trailing twelve months, ranking 29 of the 33 research & consulting services companies we cover.
- What is Enigmatig LTD's market cap?
- On September 30, 2025, Enigmatig LTD's market capitalisation was about $150M, with a price-to-earnings ratio of 268.1 and net debt of -$13.2M. Market figures come from third-party market data and may be delayed.
- Who are Enigmatig LTD's competitors?
- In our Research & Consulting Services peer group, the companies closest to Enigmatig LTD are Acco Group Holdings Ltd, Zenta Group Co Ltd, Robot Consulting Co., Ltd., Intelligent Group Ltd and Ryojbaba Co., Ltd. The side-by-side comparison below sets their revenue, margins and growth against Enigmatig LTD's.
Follow research on Enigmatig LTD
New research on the companies we cover arrives in the weekly email. Free, one email a week.